Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy

NCT ID: NCT01899898

Last Updated: 2019-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

81 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

One third of children with epilepsy have seizures that are medically intractable. Uncontrolled seizures pose a variety of risks to children, including higher rates of mortality, developmental delay and cognitive impairment. Epilepsy surgery is not a feasible option for most children with refractory epilepsy. The ketogenic diet and the modified Atkins diet have been shown to be effective alternative treatments in children with refractory epilepsy. However, these need parents to be educated, and understand complex instructions of weighing foods and diet preparation. Therefore, children with parents with low levels of literacy and poor socioeconomic status have not been able to benefit from these therapies. Also, the paucity of trained dieticians and limited availability of labeled foods in resource-constraint settings has made these dietary therapies even more inaccessible.

This study aimed to to develop a simple-to-administer variation of the modified Atkins diet for use in children with refractory epilepsy and to evaluate the efficacy and tolerability of this simplified modified Atkins diet in children with refractory epilepsy in a randomized controlled open-label trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Refractory Epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Simplified Modified Atkins Diet

Group Type EXPERIMENTAL

Simplified Modified Atkins Diet

Intervention Type OTHER

Modified Atkins diet with the following modifications:

1. Pictorial representation of various food items and exchange lists will be provided.
2. Instead of weights, we will provide standardized measures
3. We will calculate the amount of carbohydrates of daily readily available foods in the standardized measures
4. We will formulate recipes and diets based on locally available and culturally acceptable foods.
5. We will develop a parent instruction manual.
6. We will also develop methods for parents with low levels of literacy to maintain seizure logs. This will be done by using bars and color codes.
7. We will develop methods for parents with low levels of literacy to measure and record urine ketones. This will be done by using color codes.

Antiepileptic drugs alone

Group Type ACTIVE_COMPARATOR

Antiepileptic drugs alone

Intervention Type DRUG

The anti-epileptic drugs will be continued alone for 3 months following which they will be offered Simplified Modified Atkins Diet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Simplified Modified Atkins Diet

Modified Atkins diet with the following modifications:

1. Pictorial representation of various food items and exchange lists will be provided.
2. Instead of weights, we will provide standardized measures
3. We will calculate the amount of carbohydrates of daily readily available foods in the standardized measures
4. We will formulate recipes and diets based on locally available and culturally acceptable foods.
5. We will develop a parent instruction manual.
6. We will also develop methods for parents with low levels of literacy to maintain seizure logs. This will be done by using bars and color codes.
7. We will develop methods for parents with low levels of literacy to measure and record urine ketones. This will be done by using color codes.

Intervention Type OTHER

Antiepileptic drugs alone

The anti-epileptic drugs will be continued alone for 3 months following which they will be offered Simplified Modified Atkins Diet

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age: 2 - 14 years.
2. Seizures persisting daily or more than 7 per week despite the use of at least 2 anti-epileptic drugs in appropriate doses and levels (whenever available) in suitable to the syndrome and EEG findings.

Exclusion Criteria

1. Known or suspected inborn error of metabolism:

Patients with clinical suspicion of metabolic disorder as evidenced by 2 or more of the following- a history of parental consanguinity, prior affected siblings, unexplained vomiting, intermittent worsening of symptoms, recurrent episodes of lethargy, altered sensorium, or ataxia, hepatosplenomegaly on examination With or without 2 or more of the following biochemical abnormalities High blood ammonia (\>80mmol/L), High arterial lactate (\>2 mmol/L), metabolic acidosis (pH \<7.2), hypoglycaemia (blood sugar \<40 mg/dl), abnormal urinary aminoacidogram, presence of reducing sugars or ketones in urine, and positive results on urine neurometabolic screening tests.

In such patients, blood tandem mass spectrometry or urine gas chromatography mass spectroscopy (GCMS) will be obtained to look for inborn error of metabolism.
2. Surgically remediable causes of epilepsy such as tumors, cortical dysplasias, mesial temporal lobe epilepsy etc with refractory focal epilepsy.

We will perform MRI brain, and short term video-EEG in all patients with focal seizures to look for surgically remediable causes.
3. Motivational or psychosocial issues in the family which would preclude compliance
4. Systemic illness- chronic hepatic, renal or pulmonary disease
Minimum Eligible Age

2 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lady Hardinge Medical College

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Satinder Aneja

Director Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Satinder Aneja, MD

Role: PRINCIPAL_INVESTIGATOR

Pediatric Neurology, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Division of Pediatric Neurology, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital

New Delhi, National Capital Territory of Delhi, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

References

Explore related publications, articles, or registry entries linked to this study.

Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2020 Jun 24;6(6):CD001903. doi: 10.1002/14651858.CD001903.pub5.

Reference Type DERIVED
PMID: 32588435 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SMAD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intermittent Fasting in Refractory Epilepsy
NCT02311023 TERMINATED PHASE2
Thalidomide Low Threshold in Epilepsy
NCT01061866 COMPLETED PHASE1/PHASE2